Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial
Saved in:
| Title: | Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial |
|---|---|
| Authors: | Vera, Pierre1 (AUTHOR) pierre.vera@chb.unicancer.fr, Thureau, Sébastien1,2 (AUTHOR), Le Tinier, Florence3 (AUTHOR), Chaumet-Riffaud, Philippe4 (AUTHOR), Hapdey, Sébastien1 (AUTHOR), Kolesnikov-Gauthier, Hélène5 (AUTHOR), Martin, Etienne6 (AUTHOR), Berriolo-Riedinger, Alina7 (AUTHOR), Pourel, Nicolas8 (AUTHOR), Broglia, Jean Marc9 (AUTHOR), Boissellier, Pierre10 (AUTHOR), Guillemard, Sophie11 (AUTHOR), Salem, Naji12 (AUTHOR), Brenot-Rossi, Isabelle13 (AUTHOR), Le Péchoux, Cécile14 (AUTHOR), Berthold, Céline14 (AUTHOR), Giroux-Leprieur, Etienne15 (AUTHOR), Moreau, Damien16 (AUTHOR), Guillerm, Sophie17 (AUTHOR), Benali, Khadija18 (AUTHOR) |
| Source: | Lancet Oncology. Sep2024, Vol. 25 Issue 9, p1176-1187. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
